Test it yourself. If it fails, you get a full refund.
Independent test fails? Full refund.
Independent test fails? Full refund.
10 vials per kit, from 1 kit per product and strength. We reply to every quote request within 24 hours. How quotes work →
10 vials per kit · from 1 kit · reply within 24 hours Quotes →
10 vials per kit · from 1 kit Quotes →
Cagrilintide and semaglutide in equal mass, combined in one lyophilized vial
Research topic: Body & metabolism · group: GLP-1 class and amylin analogues
Cagrilintide and semaglutide share this vial in equal mass. CagriSema is the development name of the sponsor's own combination; our blend uses the two peptides but is not that formulation. Cagrilintide is a lipidated amylin analogue of 37 residues, semaglutide a lipidated GLP-1 analogue of 31, and each has a page of its own with its fact table. A mixture has no single formula, mass or CAS, so those fields stay empty and the COA of each lot reports the two components separately. It is listed in the GLP-1 and amylin group of our body-composition and metabolic page. The studies in our product data are randomised trials that combined the two peptides, from a phase 1b study to phase 3 trials in adults with overweight or obesity, with and without type 2 diabetes.
Besides the vials, Cagrilintide + Semaglutide is bottled as a nasal spray, held in stock in the United States and shipped from there.
The COA of every lot of Cagrilintide + Semaglutide reports:
Ask for the COA of the batch you are quoted; the batch number on it is the batch we ship.
Independent test fails? Full refund. How the refund works
| Field | Value | Source |
|---|---|---|
| Chemical name | Cagrilintide + Semaglutide | Our product table |
| Other names | CagriSema | Our product table |
| CAS number | Not in our product tableNo single CAS: a blend of two peptides. Each component's CAS is on its own page. | Our product table |
| Strengths (per vial) | 5 mg, 10 mg, 20 mg | Our product table |
| Kit and minimum order | 10 vials per kit · from 1 kit per strength | Our product table |
| Form | Lyophilized powder | Our product table |
| Catalogue codes | 5 mg: CAGSM5 · 10 mg: CAGSM10 · 20 mg: CAGSM20 | Our product table |
| Purity specification | ≥ 99.0% (sum of declared peptides) (HPLC)Specification; the measured value is on the COA of the lot. | Our product table |
| Appearance | White to off-white lyophilized powder | Our product table |
| Storage | Store unopened at 2–8 °C, protected from light and moisture | Our product table |
| Batch COA | Component identity · HPLC assay · endotoxin · fill volume — every lot | Our batch COA |
Product-table values checked 2026-10-09. The measured values of a lot are on its COA.
| First author / trial | Year | Journal | What was studied | Record |
|---|---|---|---|---|
| Enebo LB | 2021 | Lancet | Randomised phase 1b trial of cagrilintide combined with semaglutide(combination) | PubMed 33894838 |
| Frias JP | 2023 | Lancet | Cagrilintide with semaglutide in type 2 diabetes(combination) | PubMed 37364590 |
| Garvey WT | 2025 | N Engl J Med | Phase 3 trial in adults with overweight or obesity without diabetes (REDEFINE 1)(combination) | PubMed 40544433 |
| Davies MJ | 2025 | N Engl J Med | Phase 3 trial in adults with overweight or obesity and type 2 diabetes (REDEFINE 2)(combination) | PubMed 40544432 |
| Yamauchi T | 2026 | Lancet Diabetes Endocrinol | Phase 3a trial against semaglutide alone in adults in Japan and Taiwan (REDEFINE 5)(combination) | PubMed 42009015 |
Studies recorded in our product data (checked 2026-10-09). They show what has been researched with this molecule — the materials and models of each study — and are not a statement about the vials we supply.
What to put in your quote request
With these facts the first reply can carry the unit price per kit, shipping and lead time.
No. CagriSema names the sponsor's investigational combination. Our vial holds the same two peptides as a research blend, made and documented lot by lot; it is not that formulation and not a medicine.
One to one by mass: equal amounts of cagrilintide and semaglutide. The COA of each lot gives an identity result and an assay for each component, so the ratio can be checked on it.
One kit is 10 vials of the same product at the same strength. Each vial holds the stated amount, for example 10 mg of lyophilized peptide; the few solutions are stated per vial in mg or ml. 1 kit per product and strength. One order can combine several products and strengths, each from 1 kit.
The identity of each declared component, the HPLC assay of each component, endotoxin and fill volume, on the COA of every lot. The COA carries the lot number of the vials you receive. Yes. Ask for the COA of the batch you are quoted; the batch number on that COA is the batch we ship.
In writing, per request. Prices are tiered by the number of kits of each peptide and strength; the quotation gives the unit price per kit, the shipping cost and the lead time. We reply within 24 hours.
Related peptides
37-mer
Long-acting lipidated amylin analogue of 37 residues
Nasal spray available
Lipidated GLP-1 receptor agonist peptide of 31 residues
Nasal spray available
Retatrutide and cagrilintide blended in one lyophilized vial
